BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 24990963)

  • 1. Prolyl hydroxylation by EglN2 destabilizes FOXO3a by blocking its interaction with the USP9x deubiquitinase.
    Zheng X; Zhai B; Koivunen P; Shin SJ; Lu G; Liu J; Geisen C; Chakraborty AA; Moslehi JJ; Smalley DM; Wei X; Chen X; Chen Z; Beres JM; Zhang J; Tsao JL; Brenner MC; Zhang Y; Fan C; DePinho RA; Paik J; Gygi SP; Kaelin WG; Zhang Q
    Genes Dev; 2014 Jul; 28(13):1429-44. PubMed ID: 24990963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iron chelation and 2-oxoglutarate-dependent dioxygenase inhibition suppress mantle cell lymphoma's cyclin D1.
    Babosova O; Kapralova K; Raskova Kafkova L; Korinek V; Divoky V; Prchal JT; Lanikova L
    J Cell Mol Med; 2019 Nov; 23(11):7785-7795. PubMed ID: 31517438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of cyclin D1 and breast tumorigenesis by the EglN2 prolyl hydroxylase.
    Zhang Q; Gu J; Li L; Liu J; Luo B; Cheung HW; Boehm JS; Ni M; Geisen C; Root DE; Polyak K; Brown M; Richardson AL; Hahn WC; Kaelin WG; Bommi-Reddy A
    Cancer Cell; 2009 Nov; 16(5):413-24. PubMed ID: 19878873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of hypoxia-inducible factor 1alpha (HIF-1alpha) transcriptional activity by the HIF prolyl hydroxylase EGLN1.
    To KK; Huang LE
    J Biol Chem; 2005 Nov; 280(45):38102-7. PubMed ID: 16157596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein Hydroxylation by Hypoxia-Inducible Factor (HIF) Hydroxylases: Unique or Ubiquitous?
    Strowitzki MJ; Cummins EP; Taylor CT
    Cells; 2019 Apr; 8(5):. PubMed ID: 31035491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of the Ubiquitin-Specific Peptidase 9 X-Linked (USP9X) Gene is Associated with Upregulation of Cyclin D1 (CCND1) and Downregulation of Cyclin-Dependent Inhibitor Kinase 1A (CDKN1A) in Breast Cancer Tissue and Cell Lines.
    Li H; Zheng B
    Med Sci Monit; 2019 Jun; 25():4207-4216. PubMed ID: 31169265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. USP9X promotes apoptosis in cholangiocarcinoma by modulation expression of KIF1Bβ via deubiquitinating EGLN3.
    Chen W; Song J; Liu S; Tang B; Shen L; Zhu J; Fang S; Wu F; Zheng L; Qiu R; Chen C; Gao Y; Tu J; Zhao Z; Ji J
    J Biomed Sci; 2021 Jun; 28(1):44. PubMed ID: 34112167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesis.
    Zou Y; Tsai WB; Cheng CJ; Hsu C; Chung YM; Li PC; Lin SH; Hu MC
    Breast Cancer Res; 2008; 10(1):R21. PubMed ID: 18312651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The non-canonical functions of HIF prolyl hydroxylases and their dual roles in cancer.
    Yu M; Lun J; Zhang H; Zhu L; Zhang G; Fang J
    Int J Biochem Cell Biol; 2021 Jun; 135():105982. PubMed ID: 33894356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor suppressor SPOP ubiquitinates and degrades EglN2 to compromise growth of prostate cancer cells.
    Zhang L; Peng S; Dai X; Gan W; Nie X; Wei W; Hu G; Guo J
    Cancer Lett; 2017 Apr; 390():11-20. PubMed ID: 28089830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases.
    Marxsen JH; Stengel P; Doege K; Heikkinen P; Jokilehto T; Wagner T; Jelkmann W; Jaakkola P; Metzen E
    Biochem J; 2004 Aug; 381(Pt 3):761-7. PubMed ID: 15104534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin D1 promotes anchorage-independent cell survival by inhibiting FOXO-mediated anoikis.
    Gan L; Liu P; Lu H; Chen S; Yang J; McCarthy JB; Knudsen KE; Huang H
    Cell Death Differ; 2009 Oct; 16(10):1408-17. PubMed ID: 19575018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deubiquitinase USP9X deubiquitinates β-catenin and promotes high grade glioma cell growth.
    Yang B; Zhang S; Wang Z; Yang C; Ouyang W; Zhou F; Zhou Y; Xie C
    Oncotarget; 2016 Nov; 7(48):79515-79525. PubMed ID: 27783990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EglN2 contributes to triple negative breast tumorigenesis by functioning as a substrate for the FBW7 tumor suppressor.
    Takada M; Zhuang M; Inuzuka H; Zhang J; Zurlo G; Zhang J; Zhang Q
    Oncotarget; 2017 Jan; 8(4):6787-6795. PubMed ID: 28036276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammalian EGLN genes have distinct patterns of mRNA expression and regulation.
    Lieb ME; Menzies K; Moschella MC; Ni R; Taubman MB
    Biochem Cell Biol; 2002; 80(4):421-6. PubMed ID: 12234095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia-inducible factor (HIF)-prolyl hydroxylase 3 (PHD3) maintains high
    Miikkulainen P; Högel H; Seyednasrollah F; Rantanen K; Elo LL; Jaakkola PM
    J Biol Chem; 2019 Mar; 294(10):3760-3771. PubMed ID: 30617181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inhibition of activated hepatic stellate cells proliferation by arctigenin through G0/G1 phase cell cycle arrest: persistent p27(Kip1) induction by interfering with PI3K/Akt/FOXO3a signaling pathway.
    Li A; Wang J; Wu M; Zhang X; Zhang H
    Eur J Pharmacol; 2015 Jan; 747():71-87. PubMed ID: 25498792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTEN regulates p300-dependent hypoxia-inducible factor 1 transcriptional activity through Forkhead transcription factor 3a (FOXO3a).
    Emerling BM; Weinberg F; Liu JL; Mak TW; Chandel NS
    Proc Natl Acad Sci U S A; 2008 Feb; 105(7):2622-7. PubMed ID: 18268343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nodal enhances the activity of FoxO3a and its synergistic interaction with Smads to regulate cyclin G2 transcription in ovarian cancer cells.
    Fu G; Peng C
    Oncogene; 2011 Sep; 30(37):3953-66. PubMed ID: 21532621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The von Hippel Lindau/hypoxia-inducible factor (HIF) pathway regulates the transcription of the HIF-proline hydroxylase genes in response to low oxygen.
    del Peso L; Castellanos MC; Temes E; Martin-Puig S; Cuevas Y; Olmos G; Landazuri MO
    J Biol Chem; 2003 Dec; 278(49):48690-5. PubMed ID: 14506252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.